ATIENTS with congestive heart failure (CHF) frequently demonstrate a decrease in exercise capacity, which is probably due to decreased oxygen utilization by working skeletal muscle.1),2) Previous studies have suggested that impaired vasodilatation of working skeletal muscle during exercise was the principal mechanism for the decreased skeletal muscle oxygen utilization.3)-6) Increased activity of the renin-angiotensin system in CHF may be one of the factors responsible for the decreased vasodilatory capacity of resistance vessels in CHF.7)-9)
It has been shown that captopril improves exercise capacity of patients with CHF.10),11) If exercise capacity depends on oxygen utilization by working skeletal muscle, one may anticipate that captopril improves oxygen consumption of the working skeletal muscle. However two previous studies failed to show a significant improvement of oxygen consumption of the working skeletal muscle in CHF by acute inhibition of the renin-angiotensin system by captopril.12),13) In those studies, several factors might have resulted in the failure of captopril to increase oxygen consumption of the working skeletal muscle in patients with CHF. First, the decrease in systolic blood pressure by captopril was so great that the systolic blood pressure after captopril was at shock level, which might have impaired tissue oxygen utilization. Second, plasma renin activity was not measured in their studies. It is possible that the effects of captopril on regional circulation in muscles may depend on the level of plasma renin activity.14) Accordingly, in this study, systolic blood pressure after captopril was maintained in the physiological range. We also measured plasma renin activity and examined the effects of captopril on oxygen utilization during exercise in patients with CHF with high and low plasma renin activity.
Our study demonstrated that captopril improves oxygen utilization of the working skeletal muscle during maximal handgrip exercise in patients with severe CHF and high plasma renin activity but not in patients with mild CHF and low plasma renin activity. patients with severe CHF than in control subjects. Percent oxygen extraction, FBF, FVR and FVO2 during exercise in patients with mild CHF were not different from those in control subjects (Table II) .
Effects of captopril (Tables I and II, and Fig. 2):
Captopril did not change hemodynamics at rest and during exercise in control subjects and patients with mild CHF (Tables I and II ). In contrast, captopril lowered systolic (p<0.05), and mean blood pressure (p< 0.05) at rest in patients with severe CHF. Heart rate was not altered by captopril. Captopril did not change percent oxygen extraction, FBF, FVR and FVO2 in patients with severe CHF at rest and during submaximal exercise (Table II) but significantly increased percent oxygen extraction (p<0 .05), and thus increased FVO2 in patients with severe CHF (Fig . 2) .
DISCUSSION
Our study has demonstrated1) that the vasodilatory capacity of forearm resistance vessels and maximal forearm oxygen consumption during exercise were decreased in patients with severe CHF2) and that captopril improved maximal forearm oxygen consumption during exercise in patients with severe CHF. Fig. 1 . Percent oxygen extraction (left panel) was significantly greater at rest (p<0.05) and during submaximal exercise (5kg, p<0.01) in patients with severe CHF (n=7) than in control subjects (n=7).
Forearm blood flow (FBF) (second to the left) was significantly smaller (p<0.05-0.01) in patients with severe CHF than in control subjects at rest and at all levels of exercise. Forearm vascular resistance (FVR) (second to the right) was not different between control subjects and patients with severe CHF at rest and was significantly greater (p<0.05-0.01) during submaximal (20kg) and maximal exercise in patients with severe CHF than in control subjects. Forearm oxygen consumption (FVO2) (right panel) was not different at rest and during submaximal exercise between control subjects and patients with severe CHF but was significantly smaller during maximal exercise in patients with severe CHF than in control subjects. Closed circles indicate control subjects and closed triangles indicate patients with severe CHF. *indicates p<0.05, **indicates P<0.01. Fig. 2 . Changes in percent oxygen extraction, forearm blood flow (FBF), forearm vascular resistance (FVR) and forearm oxygen consumption (FVO2) with captopril during maximal exercise in patients with severe CHF. Captopril increased percent oxygen extraction (p<0.05) and forearm oxygen consumption (p<0.01).
A: after captopril, B: before captopril.
Decreased skeletal muscle vasodilatory capacity in patients with CHF: Previous studies have demonstrated decreased blood flow of the working skeletal muscle in patients with severe CHF.3)-6) Forearm blood flow measured by strain-gauge plethysmography was significantly smaller at rest and during exercise in patients with severe CHF than in control subjects. The calculated forearm vascular resistance during submaximal and maximal exercise was significantly greater (p<0.05) in patients with severe CHF than in control subjects. These results indicate that skeletal muscle vasodilatory capacity was decreased in patients with severe CHF. These results are consistent with many previous findings obtained by using handgrip4),5) or ergometer exercise.3),6),12), 13) In the present study, forearm blood flow was measured by strain-gauge plethysmography. This technique measures blood flow of the forearm skeletal muscle and skin. Thus decreased forearm blood flow in patients with CHF measured by plethysmography may have resulted from decreased skin blood flow rather than decreased muscle blood flow. Previous studies using epinephrine iontophoresis have indicated that with this method, 50% of the foream blood flow is to the skin and 50% to the skeletal muscle in normal subjects as well as in patients with CHF.4),17) This may well explain the large but insignificant difference of FVR at rest between normal subjects and patients with severe CHF. However during exercise, muscle blood flow dominates skin blood flow. In addition, Wahren has shown complete separation of forearm muscle and cutaneous circulation during strenuous exercise.18) Thus increased FVR during exercise in patients with severe CHF was due to decreased vasodilatory capacity of the skeletal muscle rather than the skin. It has been previously demonstrated that limb resistance vessels do not dilate normally to ischemic stimuli or during exercise in patients with CHF.3)-6),17) Our patients with severe CHF also had greater forearm vascular resistance during maximal exercise than control subjects. Previous studies suggest that the decreased vasodilatory capacity of resistance vessels in patients with CHF is due to an increased vascular wall sodium content or interstitial edema.19), 20) Decreased oxygen consumption during maximal exercise in patients with CHF: In the present study, forearm oxygen consumption was normal at rest and during submaximal exercise of 15kg , tended to be decreased during submaximal exercise of 20kg and was significantly decreased during maximal exercise in patients with severe CHF compared to that in control subjects . Patients with severe CHF had lower forearm blood flow at rest and during J pn. Heart J. N ovember 1990
submaximal exercise than control subjects. However they had greater oxygen extraction, thus maintaining normal or near normal oxygen consumption at rest and during submaximal exercise. In contrast, during maximal exercise the forearm blood flow was much lower and oxygen extraction was no longer higher and thus maximal oxygen consumption was significantly lower in patients with severe CHF than in control subjects. Several aspects of the methods deserve consideration. First, in the present study, arterial O2 saturation was obtained only one time to calculate forearm oxygen consumption. If arterial desaturation occurred with handgrip exercise in CHF, calculated forearm oxygen consumption may have been erroneously low. However this possibility is unlikely. It has been shown that exercise by bicycle ergometer, which is more intense than handgrip exercise, did not alter arterial oxygen saturation.2),3) Second, we introduced a venous catheter from the antecubital vein and positioned it in a deep vein 10cm proximal to the antecubital fossa. It is possible that oxygen rich cutaneous blood might have been shunted to deep vein sampling sites. However this possibility was not likely, since Wahren has shown complete separation of forearm muscle and cutaneous circulation during strenuous forearm exercise.18) In addition, Zelis et al have applied epinephrine iontophoresis to suppress skin blood flow during handgrip exercise and have shown that oxygen consumption of the forearm was significantly lower in patients with CHF than in control subjects.17) Thus decreased forearm oxygen consumption during maximal exercise in patients with severe CHF appears not to have resulted from shunting of the cutaneous blood flow.
The finding of decreased oxygen consumption of the working skeletal muscle in patients with severe CHF in the present study is consistent with previous reports with dynamic and static handgrip exercise and bicycle ergometer.3)-6),17) Since decreased maximal oxygen consumption of the forearm during exercise resulted from decreased blood flow but not from decreased oxygen extraction, decreased vasodilatory capacity of the resistance vessels appeared to contribute to the decreased oxygen consumption.
Effects of captopril:
It has been shown that the renin-angiotensin system is activated in CHF.8),9) Our data are consistent with this finding. It also has been shown that the plasma renin activity during exercise is greater in patients with CHF than in normal subjects.7) Thus it is possible that blocking of the renin-angiotensin system may improve peripheral circulation during exercise in patients with CHF. Previous studies have demonstrated decreases in systemic and regional vascular resistance at rest and during exercise after captopril.12)-14) However, they have failed to find increases in oxygen extraction or oxygen consumption during exercise after captopril.
Wilson and Ferraro have found that captopril did not alter leg blood flow, oxygen extraction or oxygen consumption during maximal exercise using an upright bicycle ergometer in patients with CHF.13) Kugler et al also have reported that captopril decreased oxygen extraction and did not alter femoral venous oxygen content during upright exercise with an ergometer in patients with CHF.12) In contrast, we found that captopril increased forearm oxygen consumption during maximal exercise in patients with severe CHF which resulted from increased oxygen extraction.
These results are consistent with the clinical observation that captopril increases exercise capacity in patients with CHF.
The reasons for the difference in findings between this and previous studies are not clear. However, the level of perfusion pressure after captopril might have been an important factor that caused the difference.
The systolic blood pressures after captopril in the studies by Wilson et al and Kugler et al were lower than 80mmHg whereas it was 97mmHg in this study.12),13) It is possible that low perfusion pressure after captopril in previous studies may have prevented the beneficial effects of captopril on oxygen consumption during maximal exercise. We found an improvement of oxygen consumption during maximal exercise after captopril only in patients who had markedly increased plasma renin activity.
In previous studies, plasma renin activity of patients was not presented.
Although captopril increased forearm oxygen consumption by 30% during maximal exercise in patients with severe CHF, it should be noted that oxygen consumption after captopril in these patients was still much lower than that in normal control subjects or in patients with mild CHF.
In summary, blocking the renin-angiotensin system by captopril improved forearm oxygen consumption during maximal exercise in patients with severe CHF and high renin activity. Thus nutritive blood flow to the working skeletal muscle improved, which may account for the finding that captopril increases exercise capacity in patients with CHF .
